Cetrorelix Acetate
Sponsors
Seoul National University Bundang Hospital, Merck KGaA, Darmstadt, Germany, Andros Day Surgery Clinic, Università degli Studi 'G. d'Annunzio' Chieti e Pescara, University of Oxford
Conditions
HealthyIVFIn Vitro FertilizationInfertilityInfertility/SterilityPolycystic Ovarian Syndrome
Phase 3
Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
CompletedNCT01185704
Start: 2008-11-30End: 2012-02-29Updated: 2014-02-13
Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes
NCT05972902
Start: 2023-07-15End: 2023-12-31Target: 387Updated: 2023-08-02
A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
RecruitingNCT07340827
Start: 2026-02-05End: 2029-06-30Target: 333Updated: 2026-03-18
Phase 4
Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles
TerminatedNCT03181685
Start: 2016-12-20End: 2019-12-31Updated: 2020-01-10
Cetrorelix and Ganirelix Flexible Protocol for (IVF)
NCT03477929
Start: 2017-11-15End: 2019-01-15Target: 100Updated: 2018-03-27
Frozen Embryo Transfer With GnRH-antagonist Trial
NCT03763786
Start: 2018-12-13End: 2021-01-31Target: 300Updated: 2019-04-25